Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Brooklyn ImmunoTherapeutics, Inc. Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company’s Future During May 25, 2021 Shareholder Update Call May 26, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing May 24, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc. May 21, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call Tuesday May 25, 2021 at 4:30 PM ET May 18, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Christopher Rohde, Ph.D. to Join Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc. May 13, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Brooklyn ImmunoTherapeutics Announces Publication of Results of IRX-2 Monotherapy in Early Stage Breast Cancer in Breast Cancer Research May 11, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Erich Mohr, Ph.D., to Join the Board of Directors of Brooklyn ImmunoTherapeutics May 07, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Matthew During, M.D., Ph.D. to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics April 26, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Brooklyn ImmunoTherapeutics Pays $1 Million Towards Acquisition of License for mRNA Technology Platform to Develop Genetically Edited Cells for Multiple Cancers and Blood Disorders April 15, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc. April 15, 2021 From Brooklyn ImmunoTherapeutics, Inc. Via Business Wire Tickers BTX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.